Reactive oxygen species and aldehyde dehydrogenase 1A as prognosis and theragnostic biomarker in acute myeloid leukaemia patients.

sefaldin (ABD-3001) - Advanced BioDesign

http://www.ncbi.nlm.nih.gov/pubmed/39392121

A Tichadou; C Baier; G Martin; G Venton; I Arnoux; I Ceylan; J Colle; J Quessada; L De Lassus; M Loosveld; M Pérez; N Abbou; R Costello; Y Labiad

Oct 11, 2024